Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide Jeito selects Pulmocide as its fourth investment since launching the fundPulmocide is a late-stage biopharma...

Jeito Capital leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and leader in rare skeletal disorders Jeito Capital leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and leader in rare skeletal disorders Jeito’s third international investment in H2 2020, with deep and rapidly...

Sanofi selects Jeito Capital as its first investment into a private French-based fund Sanofi selects Jeito Capital as its first investment into a private French-based fund Paris, France, 13 November 2020 – Jeito Capital (“Jeito”), a rapidly emerging independent investor dedicated...

Jeito Capital becomes major investor in SparingVision as part of €44.5 Million financing Jeito Capital becomes major investor in SparingVision as part of €44.5 Million financing Jeito Capital has selected SparingVision as its first French investment following the fund I launch in...

Jeito Capital co-leads $110 Million Series A Financing in Neogene Therapeutics Jeito Capital co-leads $110 Million Series A Financing in Neogene Therapeutics Neogene becomes Jeito Capital’s first investment following the fund I launch in January 2020Round co-led by Jeito...